HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dihydrofolate reductase (DHRF) 19-bp intron-1 deletion and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms in breast cancer.

AuthorsRagip Cam, Aydan Eroglu, Yonca Egin, Nejat Akar
JournalBreast cancer research and treatment (Breast Cancer Res Treat) Vol. 115 Issue 2 Pg. 431-2 (May 2009) ISSN: 1573-7217 [Electronic] Netherlands
PMID18498051 (Publication Type: Letter)
Chemical References
  • Methylenetetrahydrofolate Reductase (NADPH2)
  • Tetrahydrofolate Dehydrogenase
Topics
  • Breast Neoplasms (genetics)
  • DNA Mutational Analysis
  • Female
  • Genetic Predisposition to Disease
  • Humans
  • Introns
  • Methylenetetrahydrofolate Reductase (NADPH2) (genetics)
  • Polymerase Chain Reaction
  • Polymorphism, Single Nucleotide
  • Sequence Deletion
  • Tetrahydrofolate Dehydrogenase (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: